Morgan Stanley is a global financial-services firm spanning institutional securities, wealth management, and investment management. To establish a central target, 13 individual analyst price targets were collected from identifiable firms with recent dates, and the arithmetic mean was calculated at roughly $214.60, rounded to $215.
The reviewed targets span a wide range, from $190 at Citi to $260 at UBS, with data providers reporting a broader consensus range of roughly $185 to $262. Notable recent views include BofA at $220 (Buy), Keefe Bruyette at $230 (Outperform), Wells Fargo at $217 (Equal Weight), BMO Capital at $210 (Outperform), Evercore ISI at $205 (Outperform), TD Cowen at $205 (Hold), Goldman Sachs at $200 (Neutral), JPMorgan at $198 (Neutral), and RBC Capital at $195 (Sector Perform).
Importantly, many firms trimmed targets following the company's third-quarter report even though results beat expectations — RBC cut from $243 to $195, and Evercore ISI from $215 to $205 — signaling that analysts see the earnings as strong but already partly reflected in the price. The bullish camp emphasizes wealth-management growth and capital markets momentum, while the cautious camp argues the valuation leaves limited upside.
The stock closed at $178.47 on October 19, 2026, against a 52-week range of $152.80 to $232.25. Reaching the $215 central target would require a gain of roughly 20.5%, a substantial move from current levels. The shares trade at a trailing P/E (price-to-earnings ratio) of about 14 and yield about 2.6%.
The path toward the target runs through continued execution in wealth management, which posted record revenue of $9.1 billion, record net new assets of $232 billion, and fee-based flows of $80 billion in the third quarter. Institutional Securities revenue rose 18% year over year, led by a 41% jump in equities revenue. Sustaining these trends, plus a recovery in investment banking activity, would be central to any move toward $215.
Several verified fundamentals support a constructive case. Morgan Stanley's return on tangible common equity reached 22.6%, the fifth consecutive quarter above 20%. The firm repurchased $1.5 billion of stock in the quarter and maintains a strong standardized CET1 (Common Equity Tier 1) capital ratio of 14.9%. Wealth and investment management together hold $10.5 trillion in client assets, providing a recurring fee base that is less volatile than trading revenue. A rebound in advisory and underwriting fees, higher net interest income, and continued share buybacks could all support a higher stock price.
The principal obstacle is valuation and sentiment. The stock fell after its strong earnings report and now sits well below its 52-week high, suggesting investors are already pricing in much of the good news. Investment banking revenue rose only 2%, and investment management revenue declined 12% partly on a carried-interest reversal. A downturn in capital markets activity, lower equities trading volumes, a slowdown in wealth asset inflows, or rising credit provisions could all weigh on results. Higher interest rates or a market rotation away from financials could also compress the multiple.
The 52-week high of $232.25 stands as the most significant resistance level, sitting above the $215 target and representing a prior peak the stock has yet to reclaim. The $200 area, where several cautious analysts cluster, may act as interim resistance. On the downside, the $178 level near the recent close and the 52-week low of $152.80 are key support zones to watch.
Analyst price targets typically reflect a roughly 12-month research horizon, though the exact horizon varies by firm and is not always disclosed. Investors should monitor quarterly earnings, wealth-management net new assets and fee-based flows, trading and investment banking revenue, capital-return announcements, interest-rate decisions from the FOMC (Federal Open Market Committee), and any analyst target revisions. Guidance on the fourth-quarter tax rate and net interest income will also be relevant.
For investors tracking how sentiment and momentum evolve around names like Morgan Stanley, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to traditional research. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening alone. Explore the AI Daily Buy/Sell Signals to see how automated signals can support your market outlook.
The $215 central target is the average of 13 verified analyst price targets and sits about 20.5% above the current price of $178.47 — a substantial, but not extreme, required move. Support comes from record wealth-management flows, a durable fee-based franchise, and five straight quarters of above-20% return on tangible equity. The obstacles are a wide analyst range from $190 to $260, a stock that fell after beating earnings, and genuine disagreement about whether the valuation already reflects the strong results. The answer to whether Morgan Stanley can reach $215 depends on continued execution and investor willingness to pay a higher multiple; no outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MS has been closely correlated with GS. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if MS jumps, then GS could also see price increases.